DIREXION SHARES ETF TRUST
ANNUAL REPORT OCTOBER 31, 2022
1301 Avenue of the Americas (6th Ave.), 28th Floor New York, New York 10019 www.direxioninvestments.com
Direxion Auspice Broad Commodity Strategy ETF (Consolidated)
Direxion Breakfast Commodities Strategy ETF (Consolidated)
Direxion Hydrogen ETF
Direxion Moonshot Innovators ETF
Direxion mRNA ETF
Direxion Nanotechnology ETF
Direxion NASDAQ-100® Equal Weighted Index Shares
Direxion Work From Home ETF
You can find a Fund's prospectus, reports to shareholders, and other information about the Fund online at http://www.direxioninvestments.com/regulatory-documents. You can also get this information at no cost by calling (800) 851-0511 or by sending an email request to info@direxionfunds.com.
Table of Contents
Letter to Shareholders (Unaudited) |
4 |
||||||
Performance Summary (Unaudited) |
10 |
||||||
Expense Example (Unaudited) |
18 |
||||||
Allocation of Portfolio Holdings (Unaudited) |
20 |
||||||
Schedules of Investments |
21 |
||||||
Statements of Assets and Liabilities |
30 |
||||||
Statements of Operations |
32 |
||||||
Statements of Changes in Net Assets |
34 |
||||||
Financial Highlights |
38 |
||||||
Notes to the Financial Statements |
39 |
||||||
Report of
Independent Registered Public Accounting Firm |
51 |
||||||
Supplemental Information (Unaudited) |
53 |
||||||
Board Review of
Investment Advisory Agreement (Unaudited) |
54 |
||||||
Board Review of
Liquidity Risk Management Program (Unaudited) |
59 |
||||||
Trustees and Officers (Unaudited) |
60 |
Help Preserve the Environment – Go Green!
Go paperless with Direxion e-Delivery – a service allowing shareholders to reduce clutter with full online access to regulatory documents. Begin the preservation process with e-delivery.
With Direxion e-Delivery, you can:
• Receive email notifications when your most recent shareholder communications are available for review.
• Access prospectuses, annual reports and semi-annual reports online.
It's easy to enroll:
1. Visit www.direxioninvestments.com/edelivery
2. Follow the simple enrollment instructions
If you have questions about Direxion e-Delivery services, contact one of our shareholder representatives at 800-851-0511.
Letter to Shareholders (Unaudited)
Dear Shareholders,
This Annual Report for the Direxion Shares exchange traded funds (the "ETFs") covers the period from November 1, 2021 to October 31, 2022 (the "Annual Period").
Market Review:
Signs of broad-based inflation began in the fall of 2021, leading to a shaky global equity market environment. At the time, most experts predicted inflation levels were transitory, quelling investor concerns temporarily. Equity markets began to pick up through December, ending the year on a high. However, it soon became clear the widespread inflation was not going anywhere and the Federal Reserve announced an acceleration of monetary policy that was implemented through a series of interest rate hikes to combat inflation. Simultaneously, the highly contagious Covid-19 Omicron variant spread across the world and, despite high vaccination rates, breakthrough infections were at an all-time high. However, by the end of the Annual Period, Covid was far less of a concern for investors. Just as markets were looking up again, with the S&P 500 posting its first monthly gain in March 2022, Russia invaded Ukraine, and the effects of the invasion rippled across equity markets, as energy prices surged and fears of wider-spread conflict grew. In response, the United States and other western nations imposed extreme economic sanctions on Russia. Markets were very volatile on the heels of the Russian invasion, and the first two quarters of 2022 saw a shrinking U.S. GDP. June earnings reports were surprisingly strong, despite a mid-month S&P low. Despite these numbers, July was a strong month, but this positive sentiment did not last long. A hawkish speech from Federal Reserve Chair, Jerome Powell, in August negatively impacted markets around the world. September was another rough month for equities, with both the S&P 500 and NASDAQ dropping roughly 10%. Global markets fared no better, as the UK entered a recession, and China faced mass protests and unrest. October saw a modest increase in stocks as the Federal Reserve indicated it will pull back on its aggressive tightening in the near future after positive third quarter readings, but overall sentiment was still generally low. Investors are pivoting towards more risk-off investments in an attempt to navigate historic inflation levels, geopolitical conflict and high interest rates, although traditional safe haven investments, such as commodities, are less appealing than they have been in the past.
The U.S. bond market was in consistent decline for the majority of the Annual Period, oftentimes diverging from trends in the equities markets. In the fall, treasuries and international bonds were experiencing the worst performance of the Annual Period, as concerns over rising interest rates and inflation began. As inflation worsened and proved to be less transitory than initially predicted, central banks around the world pivoted towards more hawkish policies. In December, the Federal Reserve announced there would be three or four rate hikes throughout 2022, as well as a tapering of U.S. treasury asset purchases. In late February, the Russian invasion of Ukraine rippled through the global financial system, including fixed income markets. The U.S. Treasury yield curve started to flatten as the 10 – 20 year bond spread grew and became inverted. While bonds have typically been considered a way to hedge a portfolio against equities, this strategy has not typically held true in the current market environment. After the positive indication that the Federal Reserve is starting to get a handle on inflation, the global bond market saw a slight rebound, but the yield curve remained inverted at the end of the Annual Period, which remains a concern for many investors.
Factors Affecting the ETFs Performance:
Benchmark Performance – The performance of each ETF's benchmark index, and the factors and market conditions implicitly affecting that index, are the primary factors driving ETF performance. The market conditions that affected the benchmark indexes during the past year are described in the Market Review section above.
Fees, Expenses, and Transaction Costs – Fees and expenses are listed in each ETF's prospectus and may be higher than many traditional index funds' fees, which cause a greater negative impact on ETF performance. Transaction costs are not included in the expense ratio of the ETFs.
DIREXION
ANNUAL REPORT
4
The ETFs Performance Review:
The following discussion relates to the performance of the ETFs for the Annual Period. The performance of the ETFs for the Annual Period is important primarily for understanding whether the ETFs meet their investment goals. All ETF returns are NAV (net asset value) returns.
Non-Leveraged ETFs
The Direxion Auspice Broad Commodity Strategy ETF seeks investment results, before fees and expenses, that track the Auspice Broad Commodity Index over a complete market cycle. The Auspice Broad Commodity Index seeks to capture the majority of the commodity upside returns, while seeking to mitigate downside risk. The Auspice Broad Commodity Index will use a quantitative methodology to track either long or flat positions in a diversified portfolio of 12 different commodity futures contracts, or "components", which cover the energy, metal, and agricultural sectors. It attempts to incorporate dynamic risk management and contract rolling methods. For the Annual Period, the Auspice Broad Commodity Index returned 6.21%, while the Direxion Auspice Broad Commodity Strategy ETF returned 6.09%.
Until the last few months of the Annual Period, commodities had rallied in an otherwise bear market, primarily due to inflation. In particular, the energy and agriculture holdings of the Direxion Auspice Broad Commodity Strategy ETF performed well. Heating oil futures were up 58.69% and natural gas futures were up 55.64% over the Annual Period. The performance for metals was less positive, with silver down 20.59%, gold down 8.47%, and copper down 21.33%. The Direxion Auspice Broad Commodity Strategy ETF had relatively strong performance despite overall market volatility, largely due to the favorable commodity environment in the beginning-to-middle of 2022.
The Direxion Breakfast Commodities Strategy ETF seeks investment results, before fees and expenses, that track the S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index. The S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index measures the performance of tradeable commodities considered to be breakfast foods (corn, coffee, lean hogs, sugar, Chicago wheat and orange juice) by investing in monthly futures contracts for such commodities. The Index is world production weighted and designed to reflect the relative significance of each of the commodities to the world economy, except for orange juice which is capped at 5%. The Index is rebalanced annually and employs a flexible monthly futures rolling strategy. Since the Fund's inception on June 1, 2022, the S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index returned -9.04%, while the Direxion Breakfast Commodities Strategy ETF returned -8.19%.
The Direxion Breakfast Commodities Strategy ETF opened during the commodity rally. Soon after, the commodity market began to fall as many headwinds hit the space, including the Russia-Ukraine conflict, widespread droughts and labor shortages, just to name a few. Lean Hogs, Corn, Orange Juice and Sugar have had positive returns since the fund's inception, while Coffee and Wheat have fallen.
The Direxion Hydrogen ETF seeks investment results, before fees and expenses, that track the Indxx Hydrogen Economy Index. The Indxx Hydrogen Economy Index tracks the performance of companies that provide goods and/or services related to the Hydrogen Industry, including hydrogen generation and storage, fuel cells, hydrogen stations, and hydrogen-based vehicles. The Index includes domestic securities as well as securities listed on various foreign markets, including among others, Japan and South Korea. The Index is reconstituted annually and rebalanced quarterly. For the Annual Period, the Indxx Hydrogen Economy Index returned -45.79%, while the Direxion Hydrogen ETF returned -45.57%.
Kaori Heat Treatment was the top performer, while ITM Power Plc brought up the rear for the Direxion Hydrogen ETF. Two of the biggest names in the hydrogen industry, Plug Power (PLUG) and Bloom Energy (BE), experienced significant losses during the Annual Period. However, hydrogen is gaining momentum as an important source for the global energy transition, especially after the passage of the Inflation Reduction Act, which includes provisions for hydrogen tax credits.
The Direxion Moonshot Innovators ETF seeks investment results, before fees and expenses, that track the S&P Kensho Moonshots Index. The S&P Kensho Moonshots Index is comprised of 50 U.S. companies that pursue innovative technologies that have the potential to disrupt existing technologies and/or industries (i.e., moonshot innovators) and are considered to
DIREXION
ANNUAL REPORT
5
have the highest "early-stage composite innovation scores" which is determined based off a natural language processing review of the constituent company's latest annual regulatory filing for the use of words and phrases that are related to innovation. The Index is modified equal-weighted, reconstituted annually, and rebalanced semi-annually. For the Annual Period, the S&P Kensho Moonshots Index returned -60.92%, while the Direxion Moonshot Innovators ETF returned -60.64%.
Some more well-known names, such as Yelp and Roblox, experienced losses during the Annual Period. Adeia Inc. and Innoviz Technologies were the top performers for the Direxion Moonshot Innovators ETF this Annual Period. Overall, tech names have had difficulties recently, and IT companies make up roughly 50% of the portfolio.
The Direxion mRNA ETF seeks investment results, before fees and expenses, that track the BITA Messenger RNA Technology Index. The BITA Messenger RNA Technology Index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA ("mRNA") technology. mRNA is a single-stranded ribonucleic acid ("RNA") molecule that is complementary to one of the DNA strands of a gene. mRNA plays a vital role in protein synthesis in the human body, and mRNA technologies leverage this vital role to enable targeted cells to produce proteins that enable the body to fight or prevent a given disease. As an example, mRNA technology is the basis for certain COVID-19 vaccines. Eligible companies must meet certain conditions as specified by the Index Provider as well as market capitalization and liquidity requirements. Index constituents are weighted based on a modified free float market capitalization and reconstituted and rebalanced quarterly. Since the Fund's inception on December 9, 2021, the BITA Messenger RNA Technology Index returned -43.11%, while the Direxion mRNA ETF returned -43.20%.
The top performer for the Direxion mRNA ETF during the Annual Period was Vertex Pharmaceuticals (VRTX), which returned 68.28% and has a portfolio weight of 7.37%, which is one of the highest weighted stocks in the Direxion mRNA ETF. Well-known bio tech companies Moderna (MRNA) and Bio N Tech (BNTX) experienced similar losses of -55.4% and -49.1%, respectively. Curevac (CVAC) was the worst performer, losing -82.71% this Annual Period, with a weight of 4.01%.
The Direxion Nanotechnology ETF seeks investment results, before fees and expenses, that track the S&P Kensho Extended Nanotechnology Index. The S&P Kensho Extended Nanotechnology Index, a subsector index within the S&P Kensho New Economy Index Series, is designed to measure the performance of U.S. listed securities, including depositary receipts, of companies involved in the nanotechnology industry. The Index Provider defines nanotechnology as the creation and/or manipulation of matter at the molecular (or smaller) level. The Index includes companies that produce nanomaterials or provide systems, products and services that allow for construction, measurement, simulation or manipulation of nanomaterials. Since the Fund's inception on November 23, 2021, the S&P Kensho Extended Nanotechnology Index returned -35.25%, while the Direxion Nanotechnology ETF returned -35.44%.
Liquidia Corp (LQDA), Cabot Corp (CBT), and Alnylam Pharmaceuticals (ALNY) were the top performers for the Direxion Nanotechnology ETF this Annual period. However, many other names in the healthcare sector, which makes up nearly 70% of the Direxion Nanotechnology ETF, did not fare as well. Well-known Moderna (MRNA) returned -55.41% and Bio N Tech (BNTX) returned -49.15% during the period, each with a portfolio weight of roughly 3%. Bruker Corp. (BRKR) is the top holding, making up 11.47% of the portfolio, and lost -23.64% this period.
The Direxion NASDAQ-100® Equal Weighted Index Shares seeks investment results, before fees and expenses, that track the NASDAQ-100® Equal Weighted Index. The NASDAQ-100® Equal Weighted Index is the equal weighted version of the NASDAQ-100 Index® which includes approximately 100 of the largest domestic and international non-financial companies listed on the NASDAQ® Stock Market based on market capitalization selected by NASDAQ, Inc., the index provider. Equal weighting is a method of weighting index stocks whereby the same exposure is provided to both the smallest and largest companies included in the Index. The Index is rebalanced quarterly and reconstituted annually. For the Annual Period, the NASDAQ-100® Equal Weighted Index returned -23.58%, while the Direxion NASDAQ-100® Equal Weighted Index Shares returned -23.78%.
The top performers for the Direxion NASDAQ-100® Equal Weighted Index Shares during this period were largely biotech name,s including Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) returning 33.15% and 68.28%, respectively. The IT sector had a rough year, with names like Netflix, Docusign, and Meta losing -60% to -70% each.
DIREXION
ANNUAL REPORT
6
The Direxion Work From Home ETF seeks investment results, before fees and expenses, that track the Solactive Remote Work Index. The Solactive Remote Work Index is comprised of U.S. listed securities and ADRs of companies that provide products and services in at least one of the following business segments that facilitate the ability of people to work from home: remote communications, cyber security, online project and document management, and cloud computing technologies ("WFH Industries"). The Index consists of 40 companies, namely, the top 10 ranked companies in each of the four WFH Industries. The Index is equal weighted at each semi-annual reconstitution and rebalance date. For the Annual Period, the Solactive Remote Work Index returned -42.95%, while the Direxion Work From Home ETF returned -43.00%.
IBM was the top performer for the Direxion Work From Home ETF during the Annual Period, returning 20.60%. Names such as Agora and RingCentral were among bottom performers, falling -88.27% and -85.93%, respectively. Names in the IT sector make up 86.99% of the Direxion Work From Home ETF, and tech generally had a rough year.
Index Volatility:
The Annual Period was extremely volatile, leaving investors without a clear strategy, and no clear sector winner. Typically defensive stocks were not immune to the volatility, and the market cycles were moving unpredictably. The VIX Index, a measure of volatility and market sentiment, averaged 25.20 during the Annual Period, with a high of 36.45 in early March 2022, whereas the average for the previous five years was 20.94.
Index |
Return |
Volatility |
|||||||||
Auspice Broad Commodity Index |
6.09 |
% |
12.14 |
% |
|||||||
S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index1 |
-9.04 |
% |
20.23 |
% |
|||||||
Indxx Hydrogen Economy Index |
-45.79 |
% |
34.81 |
% |
|||||||
S&P Kensho Moonshots Index |
-60.92 |
% |
55.61 |
% |
|||||||
BITA Messenger RNA Technology Index2 |
-43.11 |
% |
47.45 |
% |
|||||||
S&P Kensho Extended Nanotechnology Index3 |
-35.25 |
% |
47.33 |
% |
|||||||
NASDAQ-100® Equal Weighted Index |
-23.58 |
% |
29.06 |
% |
|||||||
Solactive Remote Work Index |
-42.95 |
% |
36.66 |
% |
1 June 1, 2022 through October 31, 2022
2 December 9, 2021 through October 31, 2022
3 November 23, 2021 through October 31, 2022
As always, we thank you for using the Direxion Shares ETFs and we look forward to our mutual success.
Best Regards,
|
|
||||||
Patrick Rudnick |
Corey Noltner |
||||||
Principal Executive Officer |
Principal Financial Officer |
An investor should carefully consider a Fund's investment objective, risks, charges, and expenses before investing. A Fund's prospectus and summary prospectus contain this and other information about the Direxion Shares. To obtain a Fund's prospectus and summary prospectus call 866-476-7523 or visit our website at direxion.com. A Fund's prospectus and summary prospectus should be read carefully before investing.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate. An investor's shares, when redeemed,
DIREXION
ANNUAL REPORT
7
may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted. Returns for performance under one year are cumulative, not annualized. For the most recent month-end performance please visit the Fund's website at direxion.com.
Short-term performance, in particular, is not a good indication of the Fund's future performance, and an investment should not be made based solely on returns. Because of ongoing market volatility, Fund performance may be subject to substantial short-term changes. For additional information, see the Fund's prospectus.
Shares of the Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from a Fund. Market Price returns are based upon the midpoint of the bid/ask spread at 4:00 pm EST (when NAV is normally calculated) and do not represent the returns you would receive if you traded shares at other times. Brokerage commissions will reduce returns. Fund returns assume that dividends and capital gains distributions have been reinvested in the Fund at NAV.
SOFR (Secured Overnight Financing Rate) is a broad measure of the cost of borrowing cash overnight collateralized by Treasury securities. Futures Contract: an agreement traded on an organized exchange to buy or sell assets, especially commodities or shares, at a fixed price but to be delivered and paid for later.
Direxion Auspice Broad Commodity Strategy ETF and Direxion Breakfast Commodities Strategy ETF – Commodities and futures generally are volatile and are not suitable for all investors. The value of a commodity-linked derivative investment typically is based upon the price movements of a physical commodity and may be affected by changes in overall market movements, volatility of the underlying index, changes in interest rates, or factors affecting a particular industry or commodity, such as drought, floods, weather, embargoes, tariffs and international economic, political and regulatory developments. Commodity linked derivatives also may be subject to credit and interest rate risks that in general affect the values of debt securities. A Fund's investments in derivatives may pose risks in addition to, and greater than, those associated with directly investing in securities or other investments, including risk related to leverage, imperfect correlations with underlying investments or a Fund's other portfolio holdings, higher price volatility, lack of availability, counterparty risk, liquidity, valuation and legal restrictions. The use of derivatives is a highly specialized activity that involves investment techniques and risks different from those associated with ordinary portfolio securities transactions. Futures contracts are typically exchange traded contracts that call for the future delivery of an asset at a certain price and date, or cash settlement of the terms of the contract. Futures markets are highly volatile and the use of futures may increase the volatility of a Fund. There may be an imperfect correlation between the changes in market value of the securities held by a Fund and the prices of futures contracts. There may not be a liquid secondary market for the futures contracts.
Under amended regulations promulgated by the U.S. Commodities Futures Trading Commission ("CFTC"), a Fund and its Subsidiary are considered commodity pools, and therefore each is subject to regulation under the Commodity Exchange Act and CFTC rules. The Adviser is registered as a commodity pool operator ("CPO") and will manage the Funds and Subsidiaries in accordance with CFTC rules, as well as the rules that apply to registered investment companies, which includes registering both each Fund and its Subsidiary as commodity pools. Registration as a commodity pool subjects the registrant to additional laws, regulations and enforcement policies, all of which may potentially increase compliance costs and may affect the operations and financial performance of each Fund or its Subsidiary. Additionally, a Subsidiary's positions in futures contracts may have to be liquidated at disadvantageous times or prices to prevent a Fund from exceeding any applicable position limits established by the CFTC. Such actions may subject the Fund to substantial losses.
Direxion Shares ETF Risks – An investment in the ETFs involves risk, including the possible loss of principal. The ETFs are subject to certain risks, including imperfect index correlation and market price variance, that may decrease performance. As non-diversified funds, the ETFs may invest in a relatively small number of issuers and, as a result, be subject to greater risk of loss with respect to its portfolio securities. An ETF may concentrate its investments in certain industries or sectors, which can increase volatility. The ETFs may experience greater fluctuation in its net asset value as compared to other investments. These ETFs may be appropriate for investors
DIREXION
ANNUAL REPORT
8
with a long-term investment time horizon, who primarily seek capital growth, and who are able to tolerate periods of prolonged price declines. Please read each ETF's prospectus for a more complete description of the investment risks. There is no guarantee that an ETF will achieve its investment objective. The views of this letter were those of the Adviser as of October 31, 2022 and may not necessarily reflect its views on the date this letter is first published or anytime thereafter. These views are intended to help shareholders in understanding the ETFs' present investment methodology and do not constitute investment advice.
Distributed by: Foreside Fund Services, LLC
DIREXION
ANNUAL REPORT
9
Direxion Auspice Broad Commodity Strategy ETF (Consolidated)
Performance Summary (Unaudited)
March 30, 20171 - October 31, 2022
Average Annual Total Return2 |
|||||||||||||||||||
1 Year |
3 Year |
5 Year |
Since Inception |
||||||||||||||||
Direxion Auspice
Broad Commodity Strategy ETF (Consolidated) (NAV) |
6.21 |
% |
14.01 |
% |
8.63 |
% |
6.75 |
% |
|||||||||||
Direxion Auspice
Broad Commodity Strategy ETF (Consolidated) (Market Price) |
5.86 |
% |
13.97 |
% |
8.57 |
% |
6.72 |
% |
|||||||||||
Auspice Broad Commodity Index |
6.09 |
% |
14.09 |
% |
7.81 |
% |
5.78 |
% |
The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.70%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than the following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.
This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.
The Auspice Broad Commodity Index is a tactical long strategy that focuses on Momentum and Term Structure to track either long or flat positions in a diversified portfolio of commodity futures which cover the energy, metal, and agricultural sectors. The index incorporates dynamic risk management and contract rolling methods. The index is available in total return (collateralized) and excess return (non-collateralized) versions. Investors cannot invest directly in an index, although they can invest in its underlying securities.
Market Exposure
The Fund seeks daily exposure of 100% of its NAV through derivatives. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.
1 Commencement of operations.
2 As of October 31, 2022.
DIREXION
ANNUAL REPORT
10
Direxion Breakfast Commodities Strategy ETF (Consolidated)
Performance Summary (Unaudited)
June 1, 20221 - October 31, 2022
Total Return2 |
|||||||
Since Inception |
|||||||
Direxion Breakfast Commodities Strategy ETF (Consolidated) (NAV) |
-8.19 |
% |
|||||
Direxion Breakfast Commodities Strategy ETF (Consolidated) (Market Price) |
-8.23 |
% |
|||||
S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index |
-9.04 |
% |
The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.70%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.
This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.
The S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index measures the performance of tradeable commodities considered to be breakfast foods (corn, coffee, lean hogs, sugar, Chicago wheat and orange juice) by investing in monthly futures contracts for such commodities. The Index is world production weighted and designed to reflect the relative significance of each of the commodities to the world economy, except for orange juice is capped at 5%. Investors cannot invest directly in an index, although they can invest in its underlying securities.
Market Exposure
The Fund seeks daily exposure of 100% of its NAV through derivatives. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.
1 Commencement of operations.
2 As of October 31, 2022.
DIREXION
ANNUAL REPORT
11
Direxion Hydrogen ETF
Performance Summary (Unaudited)
March 25, 20211 - October 31, 2022
Average Annual Total Return2 |
|||||||||||
1 Year |
Since Inception |
||||||||||
Direxion Hydrogen ETF (NAV) |
-45.57 |
% |
-32.69 |
% |
|||||||
Direxion Hydrogen ETF (Market Price) |
-45.84 |
% |
-32.64 |
% |
|||||||
Indxx Hydrogen Economy Index |
-45.79 |
% |
-30.48 |
% |
The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.45%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.
This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.
The Indxx Hydrogen Economy Index tracks the performance of companies that provide goods and/or services related to the Hydrogen Industry, including hydrogen generation and storage, fuel cells, hydrogen stations, and hydrogen-based vehicles. The Index will include domestic securities as well as securities listed on various foreign markets, including among others, Japan and South Korea. The Index is reconstituted annually and rebalanced quarterly. Investors cannot invest directly in an index, although they can invest in its underlying securities.
Market Exposure
The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.
1 Commencement of operations.
2 As of October 31, 2022.
DIREXION
ANNUAL REPORT
12
Direxion Moonshot Innovators ETF
Performance Summary (Unaudited)
November 12, 20201 - October 31, 2022
Average Annual Total Return2 |
|||||||||||
1 Year |
Since Inception |
||||||||||
Direxion Moonshot Innovators ETF (NAV) |
-60.64 |
% |
-27.31 |
% |
|||||||
Direxion Moonshot Innovators ETF (Market Price) |
-60.61 |
% |
-27.31 |
% |
|||||||
S&P Kensho Moonshots Index |
-60.92 |
% |
-27.79 |
% |
The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.65%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.
This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.
The S&P Kensho Moonshots Index is comprised of 50 U.S. companies that pursue innovative technologies that have the potential to disrupt existing technologies and/or industries (i.e., moonshot innovators) and are considered to have the highest "early-stage composite innovation scores" which is determined based off a natural language processing review of the constituent company's latest annual regulatory filing for the use of words and phrases that are related to innovation. The Index is modified equal-weighted, reconstituted annually, and rebalanced semi-annually. Investors cannot invest directly in an index, although they can invest in its underlying securities.
Market Exposure
The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.
1 Commencement of operations.
2 As of October 31, 2022.
DIREXION
ANNUAL REPORT
13
Direxion mRNA ETF
Performance Summary (Unaudited)
December 9, 20211 - October 31, 2022
Total Return2 |
|||||||
Since Inception |
|||||||
Direxion mRNA ETF (NAV) |
-43.20 |
% |
|||||
Direxion mRNA ETF (Market Price) |
-43.17 |
% |
|||||
BITA Messenger RNA Technology Index |
-43.11 |
% |
The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.65%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.
This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.
BITA Messenger RNA Technology Index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA ("mRNA") technology. Investors cannot invest directly in an index, although they can invest in its underlying securities.
Market Exposure
The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.
1 Commencement of operations.
2 As of October 31, 2022.
DIREXION
ANNUAL REPORT
14
Direxion Nanotechnology ETF
Performance Summary (Unaudited)
November 23, 20211 - October 31, 2022
Total Return2 |
|||||||
Since Inception |
|||||||
Direxion Nanotechnology ETF (NAV) |
-35.44 |
% |
|||||
Direxion Nanotechnology ETF (Market Price) |
-35.45 |
% |
|||||
S&P Kensho Extended Nanotechnology Index |
-35.25 |
% |
The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.65%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.
This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.
S&P Kensho Extended Nanotechnology Index is provided by S&P Dow Jones Indices LLC (the "Index Provider") and is designed to measure the performance of U.S.-listed securities, including depositary receipts, of companies involved in the nanotechnology industry. Investors cannot invest directly in an index, although they can invest in its underlying securities.
Market Exposure
The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.
1 Commencement of operations.
2 As of October 31, 2022.
DIREXION
ANNUAL REPORT
15
Direxion NASDAQ-100® Equal Weighted Index Shares
Performance Summary (Unaudited)
October 31, 2012 - October 31, 2022
Average Annual Total Return1 |
|||||||||||||||||||
1 Year |
3 Years |
5 Years |
10 Years |
||||||||||||||||
Direxion NASDAQ-100® Equal Weighted Index Shares (NAV) |
-23.78 |
% |
9.51 |
% |
10.31 |
% |
14.44 |
% |
|||||||||||
Direxion NASDAQ-100® Equal Weighted Index Shares (Market Price) |
-23.68 |
% |
9.53 |
% |
10.33 |
% |
14.44 |
% |
|||||||||||
NASDAQ-100® Equal Weighted Index |
-23.58 |
% |
9.88 |
% |
10.69 |
% |
14.85 |
% |
The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.35%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.
This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.
The NASDAQ-100® Equal Weighted Index includes 100 of the largest non-financial securities listed on NASDAQ®, but instead of being weighted by market capitalization, each of the constituents is initially set at 1.00%. The Index is reviewed and adjusted annually in December, but replacements may be made any time throughout the year. The Index is rebalanced quarterly in March, June, September and December. Investors cannot invest directly in an index, although they can invest in its underlying securities.
Market Exposure
The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.
1 As of October 31, 2022.
DIREXION
ANNUAL REPORT
16
Direxion Work From Home ETF
Performance Summary (Unaudited)
June 25, 20201 - October 31, 2022
Average Annual Total Return2 |
|||||||||||
1 Year |
Since Inception |
||||||||||
Direxion Work From Home ETF (NAV) |
-43.00 |
% |
-4.67 |
% |
|||||||
Direxion Work From Home ETF (Market Price) |
-42.98 |
% |
-4.69 |
% |
|||||||
Solactive Remote Work Index |
-42.95 |
% |
-4.52 |
% |
The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.45%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.
This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.
The Solactive Remote Work Index is comprised of U.S. listed securities and American Depository Receipts of companies that provide products and services in at least one of the following business segments that facilitate the ability of people to work from home: remote communications, cyber security, online project and document management, and cloud computing technologies ("WFH Industries"). The Index consists of 40 companies, namely, the top 10 ranked companies in each of the four WFH Industries. The Index is equal weighted at each semi-annual reconstitution and rebalance date. Investors cannot invest directly in an index, although they can invest in its underlying securities.
Market Exposure
The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.
1 Commencement of operations.
2 As of October 31, 2022.
DIREXION
ANNUAL REPORT
17
Expense Example (Unaudited)
October 31, 2022
As a shareholder of the Funds, you incur two types of costs: (1) transaction costs, for purchasing and selling shares and exchange fees; and (2) ongoing costs, including management fees; and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in a fund and to compare these costs with the ongoing costs of investing in other funds.
The example is based on initial investments of $1,000 invested at the beginning of the period and held the entire period (May 1, 2022 to October 31, 2022).
Actual expenses
The first line under each Fund in the table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line for your Fund under the heading entitled "Expenses Paid During Period May 1, 2022 to October 31, 2022" to estimate the expenses you paid on your account during this period.
Hypothetical example for comparison purposes
The second line of the table below provides information about hypothetical account values and hypothetical expenses based on each Fund's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as brokerage commissions paid on purchases and sales of Fund shares. Therefore, the second line under each Fund in the table is useful in comparing ongoing Fund costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
DIREXION
ANNUAL REPORT
18
Expense Example (Unaudited)
October 31, 2022
Annualized Expense Ratio |
Beginning Account Value May 1, 2022 |
Ending Account Value October 31, 2022 |
Expenses
Paid During Period May 1, 2022 to October 31, 2022* |
||||||||||||||||
Direxion Auspice Broad Commodity Strategy ETF (Consolidated) |
|||||||||||||||||||
Based on actual fund return |
0.86 |
% |
$ |
1,000.00 |
$ |
918.50 |
$ |
4.16 |
|||||||||||
Based on hypothetical 5% return |
0.86 |
% |
1,000.00 |
1,020.87 |
4.38 |
||||||||||||||
Direxion Breakfast Commodities Strategy ETF (Consolidated)1 |
|||||||||||||||||||
Based on actual fund return |
0.70 |
% |
1,000.00 |
918.10 |
2.81 |
||||||||||||||
Based on hypothetical 5% return |
0.70 |
% |
1,000.00 |
1,018.02 |
2.96 |
||||||||||||||
Direxion Hydrogen ETF |
|||||||||||||||||||
Based on actual fund return |
0.45 |
% |
1,000.00 |
765.80 |
2.00 |
||||||||||||||
Based on hypothetical 5% return |
0.45 |
% |
1,000.00 |
1,022.94 |
2.29 |
||||||||||||||
Direxion Moonshot Innovators ETF |
|||||||||||||||||||
Based on actual fund return |
0.65 |
% |
1,000.00 |
826.40 |
2.99 |
||||||||||||||
Based on hypothetical 5% return |
0.65 |
% |
1,000.00 |
1,021.93 |
3.31 |
||||||||||||||
Direxion mRNA ETF |
|||||||||||||||||||
Based on actual fund return |
0.65 |
% |
1,000.00 |
986.10 |
3.25 |
||||||||||||||
Based on hypothetical 5% return |
0.65 |
% |
1,000.00 |
1,021.93 |
3.31 |
||||||||||||||
Direxion Nanotechnology ETF |
|||||||||||||||||||
Based on actual fund return |
0.65 |
% |
1,000.00 |
1,064.60 |
3.38 |
||||||||||||||
Based on hypothetical 5% return |
0.65 |
% |
1,000.00 |
1,021.93 |
3.31 |
||||||||||||||
Direxion NASDAQ-100® Equal Weighted Index Shares |
|||||||||||||||||||
Based on actual fund return |
0.35 |
% |
1,000.00 |
928.00 |
1.70 |
||||||||||||||
Based on hypothetical 5% return |
0.35 |
% |
1,000.00 |
1,023.44 |
1.79 |
||||||||||||||
Direxion Work From Home ETF |
|||||||||||||||||||
Based on actual fund return |
0.45 |
% |
1,000.00 |
774.50 |
2.01 |
||||||||||||||
Based on hypothetical 5% return |
0.45 |
% |
1,000.00 |
1,022.94 |
2.29 |
* Expenses are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period, multiplied by 184 days (the number of days in the period of May 1, 2022 to October 31, 2022), then divided by 365.
1 Expenses are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period from June 1, 2022 (commencement of operations) to October 31, 2022, multiplied by 153 days (the number of days since commencement of operations to October 31, 2022), then divided by 365.
DIREXION
ANNUAL REPORT
19
Allocation of Portfolio Holdings (Unaudited)
October 31, 2022
Cash* |
Common Stocks |
Futures |
Total |
||||||||||||||||
Direxion Auspice Broad Commodity Strategy ETF (Consolidated) |
100 |
% |
— |
— |
100 |
% |
|||||||||||||
Direxion Breakfast Commodities Strategy ETF (Consolidated) |
100 |
% |
— |
0 |
%** |
100 |
% |
||||||||||||
Direxion Hydrogen ETF |
1 |
% |
99 |
% |
— |
100 |
% |
||||||||||||
Direxion Moonshot Innovators ETF |
1 |
% |
99 |
% |
— |
100 |
% |
||||||||||||
Direxion mRNA ETF |
0 |
%** |
100 |
% |
— |
100 |
% |
||||||||||||
Direxion Nanotechnology ETF |
0 |
%** |
100 |
% |
— |
100 |
% |
||||||||||||
Direxion NASDAQ-100® Equal Weighted Index Shares |
0 |
%** |
100 |
% |
— |
100 |
% |
||||||||||||
Direxion Work From Home ETF |
0 |
%** |
100 |
% |
— |
100 |
% |
* Cash and other assets less liabilities.
** Percentage is less than 0.5%.
DIREXION
ANNUAL REPORT
20
Direxion Auspice Broad Commodity Strategy ETF (Consolidated)
Schedule of Investments
October 31, 2022
Shares |
Fair Value |
||||||||||
SHORT TERM INVESTMENTS - 101.3% |
|||||||||||
Money Market Funds - 101.3% |
|||||||||||
301,128,639 |
Dreyfus Government
Cash Management Institutional Shares, 2.91% (a) |
$ |
301,128,639 |
||||||||
TOTAL SHORT TERM
INVESTMENTS (Cost $301,128,639) |
$ |
301,128,639 |
|||||||||
TOTAL INVESTMENTS
(Cost $301,128,639) - 101.3% |
$ |
301,128,639 |
|||||||||
Liabilities in
Excess of Other Assets - (1.3)% |
(3,840,833 |
) |
|||||||||
TOTAL NET ASSETS - 100.0% |
$ |
297,287,806 |
Percentages are stated as a percent of net assets.
The geographic location of all investments is United States unless otherwise indicated.
(a) Represents annualized seven-day yield at October 31, 2022.
The accompanying notes are an integral part of these financial statements.
DIREXION
ANNUAL REPORT
21
Direxion Breakfast Commodities Strategy ETF (Consolidated)
Schedule of Investments
October 31, 2022
Shares |
Fair Value |
||||||||||
SHORT TERM INVESTMENTS - 91.3% |
|||||||||||
Money Market Funds - 91.3% |
|||||||||||
6,273,596 |
Dreyfus Government
Cash Management Institutional Shares, 2.91% (a) |
$ |
6,273,596 |
||||||||
TOTAL SHORT TERM
INVESTMENTS (Cost $6,273,596) |
$ |
6,273,596 |
|||||||||
TOTAL INVESTMENTS
(Cost $6,273,596) - 91.3% |
$ |
6,273,596 |
|||||||||
Other Assets in
Excess of Liabilities - 8.7% (b) |
596,427 |
||||||||||
TOTAL NET ASSETS - 100.0% |
$ |
6,870,023 |
Percentages are stated as a percent of net assets.
The geographic location of all investments is United States unless otherwise indicated.
(a) Represents annualized seven-day yield at October 31, 2022.
(b) $492,562 of cash is pledged as collateral for futures contracts.
Long Futures Contracts
October 31, 2022
Reference Entity |
Expiration Date |
Number
of Contracts |
Notional Amount |
Variation Margin Receivable/ (Payable), net |
Unrealized Appreciation (Depreciation) |
||||||||||||||||||
Coffee C |
5/18/2023 |
5 |
$ |
324,281 |
$ |
11,437 |
$ |
(60,675 |
) |
||||||||||||||
Corn |
12/14/2023 |
89 |
2,784,588 |
21,138 |
(18,721 |
) |
|||||||||||||||||
Frozen Concentrate Orange Juice |
1/10/2023 |
13 |
392,145 |
1,657 |
26,884 |
||||||||||||||||||
Lean Hogs |
12/14/2022 |
24 |
815,280 |
(11,280 |
) |
7,310 |
|||||||||||||||||
Sugar #11 |
4/28/2023 |
36 |
681,005 |
9,677 |
(69,049 |
) |
|||||||||||||||||
Wheat |
7/14/2023 |
40 |
1,807,500 |
84,500 |
147,600 |
||||||||||||||||||
$ |
6,804,799 |
$ |
117,129 |
$ |
33,349 |
All futures contracts held by Direxion BKT Fund Ltd. See Note 1.
The accompanying notes are an integral part of these financial statements.
DIREXION
ANNUAL REPORT
22
Direxion Hydrogen ETF
Schedule of Investments
October 31, 2022
Shares |
Fair Value |
||||||||||
COMMON STOCKS - 99.0% |
|||||||||||
Chemical Manufacturing - 42.1% |
|||||||||||
14,072 |
Air Liquide S.A. (France) |
$ |
1,840,032 |
||||||||
3,921 |
Air Products & Chemicals, Inc. |
981,819 |
|||||||||
52,997 |
Doosan Fuel Cell
Co., Ltd (South Korea) (a) |
1,013,843 |
|||||||||
520,629 |
ITM Power (United Kingdom) (a)(b) |
495,483 |
|||||||||
3,281 |
Linde PLC (Ireland) ADR |
975,605 |
|||||||||
27,063 |
McPhy Energy SAS (France) (a)(b) |
307,598 |
|||||||||
1,496,312 |
Nel ASA (Norway) (a) |
1,828,500 |
|||||||||
57,298 |
Nippon Sanso
Holdings Corp. (Japan) |
914,393 |
|||||||||
845,137 |
PTT Global Chemical
PCL (Thailand) |
965,934 |
|||||||||
9,323,207 |
|||||||||||
Computer and
Electronic Product Manufacturing - 8.5% |
|||||||||||
100,767 |
Bloom Energy Corp. (a) |
1,885,351 |
|||||||||
Electrical Equipment, Appliance, and Component Manufacturing - 12.4% |
|||||||||||
64,956 |
Chung-Hsin Electric
& Machinery Manufacturing Corp. (Taiwan) |
99,584 |
|||||||||
2,894 |
Hyosung Heavy
Industries (South Korea) (a) |
116,617 |
|||||||||
101,989 |
Plug Power, Inc. (a) |
1,629,784 |
|||||||||
61,132 |
PowerCell Sweden AB
(Sweden) (a)(b) |
672,148 |
|||||||||
6,495 |
SFC Energy AG (Germany) (a)(b) |
119,913 |
|||||||||
3,882 |
VARTA AG (Germany) (b) |
104,245 |
|||||||||
2,742,291 |
|||||||||||
Merchant Wholesalers, Durable Goods - 0.5% |
|||||||||||
4,084 |
Hyster-Yale Materials Handling, Inc. |
119,089 |
|||||||||
Miscellaneous Manufacturing - 0.5% |
|||||||||||
53,568 |
Hexagon Purus
Holding AS (Norway) (a) |
103,871 |
|||||||||
Oil and Gas Extraction - 18.2% |
|||||||||||
30,166 |
BP Plc (United Kingdom) ADR (a) |
1,003,925 |
|||||||||
102,805 |
CIMC Enric Holdings
Limited (Hong Kong) |
100,187 |
|||||||||
293,081 |
ENEOS Holdings, Inc. (Japan) |
965,796 |
|||||||||
43,624 |
Idemitsu Kosan Co., Ltd (Japan) |
953,867 |
|||||||||
17,853 |
Shell Plc (United Kingdom) ADR (a) |
993,162 |
|||||||||
4,016,937 |
|||||||||||
Primary Metal Manufacturing - 0.5% |
|||||||||||
30,352 |
Kaori Heat Treatment
Co., Ltd. (Taiwan) |
110,208 |
|||||||||
Transportation Equipment Manufacturing - 6.9% |
|||||||||||
270,177 |
Ballard Power
Systems, Inc. (Canada) ADR (a)(b) |
1,531,904 |
Shares |
Fair Value |
||||||||||
Utilities - 9.4% |
|||||||||||
1,008,214 |
AFC Energy Plc
(United Kingdom) (a) |
$ |
246,090 |
||||||||
144,274 |
Ceres Power Holdings
Plc (United Kingdom) (a)(b) |
544,505 |
|||||||||
311,189 |
FuelCell Energy, Inc. (a) |
970,910 |
|||||||||
4,538 |
Korea Gas Corp. (South Korea) |
110,865 |
|||||||||
15,602 |
S-Fuelcell Co., Ltd (South Korea) |
219,608 |
|||||||||
2,091,978 |
|||||||||||
TOTAL COMMON STOCKS
(Cost $35,743,613) |
$ |
21,924,836 |
|||||||||
SHORT TERM INVESTMENTS - 17.7% |
|||||||||||
Money Market Funds - 17.7% |
|||||||||||
3,905,853 |
Dreyfus Government
Cash Management Institutional Shares, 2.91% (c)(d) |
$ |
3,905,853 |
||||||||
TOTAL SHORT TERM
INVESTMENTS (Cost $3,905,853) |
$ |
3,905,853 |
|||||||||
TOTAL INVESTMENTS
(Cost $39,649,466) - 116.7% |
$ |
25,830,689 |
|||||||||
Liabilities in
Excess of Other Assets - (16.7%) |
(3,692,014 |
) |
|||||||||
TOTAL NET ASSETS - 100.0% |
$ |
22,138,675 |
Percentages are stated as a percent of net assets.
The geographic location of all investments is United States unless otherwise indicated.
(a) Non-income producing security.
(b) A portion of this security represents a security on loan.
(c) Represents annualized seven-day yield at October 31, 2022.
(d) All or a portion of this security represents an investment of securities lending collateral.
ADR - American Depository Receipt
The accompanying notes are an integral part of these financial statements.
DIREXION
ANNUAL REPORT
23
Direxion Moonshot Innovators ETF
Schedule of Investments
October 31, 2022
Shares |
Fair Value |
||||||||||
COMMON STOCKS - 99.5% |
|||||||||||
Administrative and Support Services - 5.3% |
|||||||||||
26,146 |
Roblox Corp. (a) |
$ |
1,169,772 |
||||||||
37,014 |
SentinelOne, Inc. (a) |
845,400 |
|||||||||
2,015,172 |
|||||||||||
Ambulatory Health Care Services - 2.2% |
|||||||||||
325,057 |
Invitae Corp. (a)(b) |
838,647 |
|||||||||
Chemical Manufacturing - 8.0% |
|||||||||||
58,094 |
Arcturus
Therapeutics Holdings, Inc. (a) |
1,028,264 |
|||||||||
100,579 |
BridgeBio Pharma, Inc. (a) |
1,049,039 |
|||||||||
17,590 |
Intellia Therapeutics, Inc. (a) |
928,400 |
|||||||||
3,005,703 |
|||||||||||
Computer and
Electronic Product Manufacturing - 12.1% |
|||||||||||
13,235 |
Ambarella Inc. ADR (a) |
724,352 |
|||||||||
145,420 |
Indie Semiconductor, Inc. (a) |
1,137,184 |
|||||||||
226,912 |
MicroVision, Inc. (a)(b) |
830,498 |
|||||||||
289,944 |
Nano Dimension Ltd. ADR (Israel) (a) |
719,061 |
|||||||||
109,474 |
Ondas Holdings, Inc. (a)(b) |
437,896 |
|||||||||
140,421 |
Vuzix Corp. (a)(b) |
702,105 |
|||||||||
4,551,096 |
|||||||||||
Construction of Buildings - 0.3% |
|||||||||||
114,105 |
Xos, Inc. (a) |
128,939 |
|||||||||
Electronics and Appliance Stores - 1.5% |
|||||||||||
43,982 |
UiPath, Inc. (a) |
556,372 |
|||||||||
Food Services and Drinking Places - 3.2% |
|||||||||||
31,759 |
Yelp, Inc. (a) |
1,219,863 |
|||||||||
Management of Companies and Enterprises - 1.3% |
|||||||||||
66,671 |
CureVac N.V. ADR (Netherlands) (a) |
485,365 |
|||||||||
Merchant Wholesalers, Nondurable Goods - 1.7% |
|||||||||||
133,629 |
Atara Biotherapeutics, Inc. (a) |
622,711 |
|||||||||
Miscellaneous Manufacturing - 2.8% |
|||||||||||
481,750 |
Inovio Pharmaceuticals, Inc. (a) |
1,040,580 |
|||||||||
Motion Picture and Sound Recording Industries - 1.8% |
|||||||||||
62,130 |
ADEIA, Inc. |
694,613 |
|||||||||
Nonstore Retailers - 1.8% |
|||||||||||
136,146 |
Jumia Technologies
AG ADR (Germany) (a) |
675,284 |
|||||||||
Oil and Gas Extraction - 2.3% |
|||||||||||
816,876 |
Meta Materials, Inc. (a) |
865,888 |
|||||||||
Printing and Related Support Activities - 2.2% |
|||||||||||
102,331 |
Fisker, Inc. (a)(b) |
833,998 |
|||||||||
Professional, Scientific, and Technical Services - 13.7% |
|||||||||||
46,070 |
Asana, Inc. (a) |
949,042 |
|||||||||
56,325 |
Avidity Biosciences, Inc. (a) |
804,321 |
|||||||||
79,726 |
Local Bounti Corp. (a)(b) |
235,989 |
|||||||||
9,661 |
Okta, Inc. (a) |
542,175 |
|||||||||
97,353 |
Sarcos Technology
and Robotics Corp. (a) |
196,653 |
|||||||||
42,524 |
Squarespace, Inc. (a) |
944,458 |
|||||||||
109,360 |
Tusimple Holdings, Inc. (a) |
375,105 |
|||||||||
21,177 |
Unity Software, Inc. (a) |
624,721 |
|||||||||
135,362 |
Vimeo, Inc. (a) |
514,376 |
|||||||||
5,186,840 |
Shares |
Fair Value |
||||||||||
Publishing Industries (except Internet) - 3.3% |
|||||||||||
48,851 |
C3.ai, Inc. (a) |
$ |
640,437 |
||||||||
71,657 |
Fastly, Inc. (a) |
608,368 |
|||||||||
1,248,805 |
|||||||||||
Securities, Commodity Contracts, and Other Financial Investments and Related Activities - 36.0% |
|||||||||||
240,651 |
Aeva Technologies, Inc. (a) |
481,302 |
|||||||||
345,482 |
AEye, Inc. (a) |
300,742 |
|||||||||
428,953 |
Aurora Innovation, Inc. (a) |
883,643 |
|||||||||
243,762 |
Benson Hill, Inc. (a) |
826,353 |
|||||||||
293,566 |
Butterfly Network, Inc. (a)(b) |
1,438,473 |
|||||||||
406,671 |
Desktop Metal, Inc. (a)(b) |
1,028,878 |
|||||||||
336,707 |
Ginkgo Bioworks
Holdings, Inc. Class A (a)(b) |
919,210 |
|||||||||
258,079 |
Hyliion Holdings Corp. (a) |
735,525 |
|||||||||
282,105 |
Hyzon Motors, Inc. (a) |
538,821 |
|||||||||
236,034 |
Inoviz Technologies
Ltd. ADR (Israel) (a) |
1,182,530 |
|||||||||
757,591 |
Latch, Inc. (a) |
1,015,172 |
|||||||||
536,808 |
Ouster, Inc. (a) |
671,010 |
|||||||||
155,133 |
Pear Therapeutics, Inc. (a) |
426,616 |
|||||||||
192,899 |
Planet Labs PBC (a) |
1,012,720 |
|||||||||
131,492 |
Roivant Sciences Ltd. ADR (a)(b) |
675,869 |
|||||||||
831,337 |
Velodyne Lidar, Inc. (a) |
820,945 |
|||||||||
141,477 |
Virgin Galactic Holdings, Inc. (a)(b) |
653,624 |
|||||||||
13,611,433 |
|||||||||||
TOTAL COMMON STOCKS
(Cost $66,014,382) |
$ |
37,581,309 |
|||||||||
SHORT TERM INVESTMENTS - 16.7% |
|||||||||||
Money Market Funds - 16.7% |
|||||||||||
6,325,075 |
Dreyfus Government
Cash Management Institutional Shares, 2.91% (c)(d) |
$ |
6,325,075 |
||||||||
TOTAL SHORT TERM
INVESTMENTS (Cost $6,325,075) |
$ |
6,325,075 |
|||||||||
TOTAL INVESTMENTS
(Cost $72,339,457) - 116.2% |
$ |
43,906,384 |
|||||||||
Liabilities in
Excess of Other Assets - (16.2)% |
(6,134,585 |
) |
|||||||||
TOTAL NET ASSETS - 100.0% |
$ |
37,771,799 |
Percentages are stated as a percent of net assets.
The geographic location of all investments is United States unless otherwise indicated.
(a) Non-income producing security.
(b) A portion of this security represents a security on loan.
(c) Represents annualized seven-day yield at October 31, 2022.
(d) All or a portion of this security represents an investment of securities lending collateral.
ADR - American Depository Receipt
The accompanying notes are an integral part of these financial statements.
DIREXION
ANNUAL REPORT
24
Direxion mRNA ETF
Schedule of Investments
October 31, 2022
Shares |
Fair Value |
||||||||||
COMMON STOCKS - 99.8% |
|||||||||||
Chemical Manufacturing - 58.5% |
|||||||||||
746 |
Alnylam Pharmaceuticals, Inc. (a) |
$ |
154,616 |
||||||||
81,701 |
Arbutus Biopharma
Corp. ADR (Canada) (a) |
191,180 |
|||||||||
9,187 |
Arcturus
Therapeutics Holdings, Inc. (a) |
162,610 |
|||||||||
1,286 |
BeiGene Ltd. ADR (a) |
217,192 |
|||||||||
2,786 |
Intellia Therapeutics, Inc. (a) |
147,045 |
|||||||||
3,398 |
Ionis Pharmaceuticals, Inc. (a) |
150,192 |
|||||||||
7,905 |
Maravai LifeSciences
Holdings, Inc. (a) |
131,223 |
|||||||||
7,393 |
PepGen, Inc. (a) |
90,786 |
|||||||||
32,241 |
Sangamo Therapeutics, Inc. (a) |
141,538 |
|||||||||
2,180 |
Sarepta Therapeutics, Inc. (a) |
248,564 |
|||||||||
12,474 |
Stoke Therapeutics, Inc. (a) |
185,239 |
|||||||||
822 |
Vertex Pharmaceuticals, Inc. (a) |
256,464 |
|||||||||
2,076,649 |
|||||||||||
Management of Companies and Enterprises - 4.2% |
|||||||||||
20,292 |
CureVac N.V. ADR (Netherlands) (a) |
147,726 |
|||||||||
Merchant Wholesalers, Durable Goods - 3.9% |
|||||||||||
12,268 |
Dyne Therapeutics, Inc. (a) |
139,855 |
|||||||||
Professional, Scientific, and Technical Services - 33.2% |
|||||||||||
4,568 |
Arrowhead Pharmaceuticals, Inc. (a) |
159,012 |
|||||||||
9,527 |
Avidity Biosciences, Inc. (a) |
136,046 |
|||||||||
1,802 |
BioNTech SE ADR (Germany) |
248,027 |
|||||||||
50,816 |
Gritstone bio, Inc. (a) |
163,627 |
|||||||||
2,034 |
Moderna, Inc. (a) |
305,771 |
|||||||||
106,882 |
Sorrento Therapeutics Inc. (a) |
167,805 |
|||||||||
1,180,288 |
|||||||||||
TOTAL COMMON STOCKS
(Cost $4,051,204) |
$ |
3,544,518 |
|||||||||
SHORT TERM INVESTMENTS - 0.0% (†) |
|||||||||||
Money Market Funds - 0.0% (†) |
|||||||||||
91 |
Dreyfus Government
Cash Management Institutional Shares, 2.91% (b) |
$ |
91 |
||||||||
TOTAL SHORT TERM
INVESTMENTS (Cost $91) |
$ |
91 |
|||||||||
TOTAL INVESTMENTS
(Cost $4,051,295) - 99.8% |
$ |
3,544,609 |
|||||||||
Other Assets in
Excess of Liabilities - 0.2% |
5,675 |
||||||||||
TOTAL NET ASSETS - 100.0% |
$ |
3,550,284 |
Percentages are stated as a percent of net assets.
The geographic location of all investments is United States unless otherwise indicated.
(†) Less than 0.05%.
(a) Non-income producing security.
(b) Represents annualized seven-day yield at October 31, 2022.
ADR - American Depository Receipt
The accompanying notes are an integral part of these financial statements.
DIREXION
ANNUAL REPORT
25
Direxion Nanotechnology ETF
Schedule of Investments
October 31, 2022
Shares |
Fair Value |
||||||||||
COMMON STOCKS - 99.9% |
|||||||||||
Chemical Manufacturing - 31.8% |
|||||||||||
1,280 |
Aadi Bioscience, Inc. (a) |
$ |
16,531 |
||||||||
1,909 |
Alkermes PLC ADR (Ireland) (a) |
43,334 |
|||||||||
219 |
Alnylam Pharmaceuticals, Inc. (a) |
45,390 |
|||||||||
5,630 |
Arcturus
Therapeutics Holdings, Inc. (a) |
99,651 |
|||||||||
3,407 |
Beam Therapeutics, Inc. (a) |
150,113 |
|||||||||
664 |
Cabot Corp. |
48,791 |
|||||||||
3,897 |
Generation Bio Co. (a) |
19,953 |
|||||||||
880 |
Intellia Therapeutics, Inc. (a) |
46,446 |
|||||||||
304 |
Jazz Pharmaceuticals
PLC ADR (Ireland) (a) |
43,712 |
|||||||||
513,921 |
|||||||||||
Computer and
Electronic Product Manufacturing - 39.2% |
|||||||||||
378 |
AMETEK, Inc. |
49,012 |
|||||||||
58,210 |
Bionano Genomics, Inc. (a)(b) |
136,211 |
|||||||||
2,972 |
Bruker Corp. |
183,788 |
|||||||||
167 |
Danaher Corp. |
42,029 |
|||||||||
521 |
Lumentum Holdings, Inc. (a) |
38,788 |
|||||||||
25,724 |
Nano Dimension Ltd. ADR (Israel) (a) |
63,796 |
|||||||||
334 |
NVE Corp. |
20,711 |
|||||||||
2,998 |
Seer, Inc. (a) |
23,474 |
|||||||||
83 |
Thermo Fisher Scientific, Inc. |
42,660 |
|||||||||
6,269 |
Vuzix Corp. (a)(b) |
31,345 |
|||||||||
631,814 |
|||||||||||
Machinery Manufacturing - 5.7% |
|||||||||||
226 |
IDEX Corp. |
50,242 |
|||||||||
104 |
Lam Research Corp. |
42,097 |
|||||||||
92,339 |
|||||||||||
Merchant Wholesalers, Durable Goods - 2.6% |
|||||||||||
133 |
KLA-Tencor Corp. |
42,088 |
|||||||||
Merchant Wholesalers, Nondurable Goods - 1.7% |
|||||||||||
5,100 |
PDS Biotechnology Corp. (a) |
26,724 |
|||||||||
Miscellaneous Manufacturing - 1.5% |
|||||||||||
1,761 |
AngioDynamics, Inc. (a) |
24,813 |
|||||||||
Oil and Gas Extraction - 5.0% |
|||||||||||
76,319 |
Meta Materials, Inc. (a) |
80,898 |
|||||||||
Professional, Scientific, and Technical Services - 9.1% |
|||||||||||
322 |
BioNTech SE ADR (Germany) |
44,320 |
|||||||||
10,836 |
Liquidia Technologies, Inc. (a) |
52,988 |
|||||||||
334 |
Moderna, Inc. (a) |
50,210 |
|||||||||
147,518 |
|||||||||||
Securities, Commodity Contracts, and Other Financial Investments and Related Activities - 3.3% |
|||||||||||
10,243 |
Roivant Sciences Ltd. ADR (a) |
52,649 |
|||||||||
TOTAL COMMON STOCKS
(Cost $2,012,813) |
$ |
1,612,764 |
Shares |
Fair Value |
||||||||||
SHORT TERM INVESTMENTS - 0.1% |
|||||||||||
Money Market Funds - 0.1% |
|||||||||||
144,050 | Dreyfus Government
Cash Management Institutional Shares, 2.91% (c)(d) |
$ |
144,050 |
||||||||
TOTAL SHORT TERM
INVESTMENTS (Cost $144,050) |
$ |
144,050 |
|||||||||
TOTAL INVESTMENTS
(Cost $2,156,863) - 108.9% |
$ |
1,756,814 |
|||||||||
Liabilities in
Excess of Other Assets - (8.9)% |
(142,921 |
) |
|||||||||
TOTAL NET ASSETS - 100.0% |
$ |
1,613,893 |
Percentages are stated as a percent of net assets.
The geographic location of all investments is United States unless otherwise indicated.
(a) Non-income producing security.
(b) A portion of this security represents a security on loan.
(c) Represents annualized seven-day yield at October 31, 2022.
(d) All or a portion of this security represents an investment of securities lending collateral.
ADR - American Depository Receipt
The accompanying notes are an integral part of these financial statements.
DIREXION
ANNUAL REPORT
26
Direxion NASDAQ-100® Equal Weighted Index Shares
Schedule of Investments
October 31, 2022
Shares |
Fair Value |
||||||||||
COMMON STOCKS - 99.9% |
|||||||||||
Accommodation - 1.0% |
|||||||||||
45,305 |
Marriott
International, Inc. Class A |
$ |
7,253,784 |
||||||||
Administrative and Support Services - 2.9% |
|||||||||||
28,895 |
Atlassian Corp. (a) |
5,857,884 |
|||||||||
30,040 |
Automatic Data Processing, Inc. |
7,260,668 |
|||||||||
3,740 |
Booking Holdings, Inc. (a) |
6,991,855 |
|||||||||
20,110,407 |
|||||||||||
Apparel Manufacturing - 1.0% |
|||||||||||
21,061 |
Lululemon Athletica, Inc. (a) |
6,929,911 |
|||||||||
Beverage and Tobacco Product Manufacturing - 3.2% |
|||||||||||
188,825 |
Keurig Dr Pepper, Inc. |
7,333,963 |
|||||||||
80,452 |
Monster Beverage Corp. (a) |
7,539,962 |
|||||||||
42,035 |
PepsiCo, Inc. |
7,632,715 |
|||||||||
22,506,640 |
|||||||||||
Broadcasting and Content Providers - 2.9% |
|||||||||||
18,589 |
Charter Communications, Inc. (a) |
6,833,688 |
|||||||||
203,313 |
Comcast Corp. Class A |
6,453,155 |
|||||||||
1,175,650 |
Sirius XM Holdings, Inc. (b) |
7,100,926 |
|||||||||
20,387,769 |
|||||||||||
Chemical Manufacturing - 7.8% |
|||||||||||
30,365 |
Amgen, Inc. |
8,209,178 |
|||||||||
120,907 |
AstraZeneca PLC ADR
(United Kingdom) |
7,110,540 |
|||||||||
33,701 |
Biogen, Inc. (a) |
9,552,211 |
|||||||||
106,991 |
Gilead Sciences, Inc. |
8,394,514 |
|||||||||
9,881 |
Regeneron Pharmaceuticals, Inc. (a) |
7,398,399 |
|||||||||
49,417 |
Seagen, Inc. (a) |
6,283,866 |
|||||||||
24,227 |
Vertex Pharmaceuticals, Inc. (a) |
7,558,824 |
|||||||||
54,507,532 |
|||||||||||
Clothing, Clothing Accessories, Shoe, and Jewelry Retailers - 1.0% |
|||||||||||
77,777 |
Ross Stores, Inc. |
7,442,481 |
|||||||||
Computer and Electronic Product Manufacturing - 17.6% |
|||||||||||
91,734 |
Advanced Micro Devices, Inc. (a) |
5,509,544 |
|||||||||
34,137 |
Alphabet, Inc. Class A (a) |
3,226,288 |
|||||||||
33,864 |
Alphabet, Inc. Class C (a) |
3,205,566 |
|||||||||
47,007 |
Analog Devices, Inc. |
6,704,138 |
|||||||||
46,574 |
Apple, Inc. |
7,141,657 |
|||||||||
13,968 |
Broadcom, Inc. |
6,566,636 |
|||||||||
162,093 |
Cisco Systems, Inc. |
7,363,885 |
|||||||||
139,203 |
Fortinet, Inc. (a) |
7,956,843 |
|||||||||
20,489 |
IDEXX Laboratories, Inc. (a) |
7,369,483 |
|||||||||
35,123 |
Illumina, Inc. (a) |
8,036,845 |
|||||||||
240,035 |
Intel Corp. |
6,824,195 |
|||||||||
151,426 |
Marvell Technology, Inc. |
6,008,584 |
|||||||||
106,828 |
Microchip Technology, Inc. |
6,595,561 |
|||||||||
132,803 |
Micron Technology, Inc. |
7,184,642 |
|||||||||
53,179 |
NVIDIA Corp. (a) |
7,177,570 |
|||||||||
43,883 |
NXP Semiconductors
NV ADR (Netherlands) |
6,410,429 |
Shares |
Fair Value |
||||||||||
Computer and
Electronic Product Manufacturing (continued) |
|||||||||||
56,172 |
Qualcomm, Inc. |
$ |
6,609,198 |
||||||||
70,270 |
Skyworks Solutions, Inc. |
6,043,923 |
|||||||||
42,470 |
Texas Instruments, Inc. |
6,821,956 |
|||||||||
122,756,943 |
|||||||||||
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services - 1.0% |
|||||||||||
67,741 |
Fiserv, Inc. (a) |
6,959,710 |
|||||||||
Food Manufacturing - 2.1% |
|||||||||||
116,395 |
Mondelez International, Inc. |
7,155,965 |
|||||||||
202,207 |
The Kraft Heinz Co. |
7,778,903 |
|||||||||
14,934,868 |
|||||||||||
Food Services and Drinking Places - 2.0% |
|||||||||||
17,358 |
Cintas Corp. |
7,421,413 |
|||||||||
76,866 |
Starbucks Corp. |
6,655,827 |
|||||||||
14,077,240 |
|||||||||||
General Merchandise Retailers - 6.4% |
|||||||||||
56,817 |
Amazon.com, Inc. (a) |
5,820,334 |
|||||||||
13,922 |
Costco Wholesale Corp. |
6,981,883 |
|||||||||
49,455 |
Dollar Tree, Inc. (a) |
7,838,618 |
|||||||||
167,110 |
eBay, Inc. |
6,657,662 |
|||||||||
126,759 |
JD.com, Inc. ADR (China) |
4,726,843 |
|||||||||
7,636 |
MercadoLibre, Inc. (a) |
6,884,770 |
|||||||||
106,886 |
Pinduoduo, Inc. ADR (China) (a) |
5,860,559 |
|||||||||
44,770,669 |
|||||||||||
Health and Personal Care Stores - 1.1% |
|||||||||||
204,804 |
Walgreens Boots Alliance, Inc. |
7,475,346 |
|||||||||
Machinery Manufacturing - 3.0% |
|||||||||||
78,976 |
Applied Materials, Inc. |
6,972,791 |
|||||||||
15,021 |
ASML Holding NV ADR
(Netherlands) |
7,096,221 |
|||||||||
17,151 |
Lam Research Corp. |
6,942,382 |
|||||||||
21,011,394 |
|||||||||||
Merchant Wholesalers, Durable Goods - 3.0% |
|||||||||||
63,747 |
Copart, Inc. (a) |
7,332,180 |
|||||||||
148,190 |
Fastenal Co. |
7,162,023 |
|||||||||
20,918 |
KLA-Tencor Corp. |
6,619,501 |
|||||||||
21,113,704 |
|||||||||||
Miscellaneous Manufacturing - 3.3% |
|||||||||||
28,185 |
Align Technology, Inc. (a) |
5,476,346 |
|||||||||
77,907 |
DexCom, Inc. (a) |
9,409,607 |
|||||||||
34,026 |
Intuitive Surgical, Inc. (a) |
8,386,388 |
|||||||||
23,272,341 |
|||||||||||
Motion Picture and Sound Recording Industries - 1.2% |
|||||||||||
29,229 |
Netflix, Inc. (a) |
8,531,361 |
|||||||||
Motor Vehicle and Parts Dealers - 1.2% |
|||||||||||
10,120 |
O'Reilly Automotive, Inc. (a) |
8,472,160 |
|||||||||
Performing Arts, Spectator Sports, and Related Industries - 2.0% |
|||||||||||
92,326 |
Activision Blizzard, Inc. |
6,721,333 |
|||||||||
57,659 |
Electronic Arts, Inc. |
7,262,727 |
|||||||||
13,984,060 |
The accompanying notes are an integral part of these financial statements.
DIREXION
ANNUAL REPORT
27
Direxion NASDAQ-100® Equal Weighted Index Shares
Schedule of Investments, continued
October 31, 2022
Shares |
Fair Value |
||||||||||
Professional, Scientific, and Technical Services - 11.2% |
|||||||||||
56,743 |
Baidu, Inc. ADR (China) (a) |
$ |
4,344,812 |
||||||||
112,840 |
Cognizant Technology
Solutions Corp. Class A |
7,024,290 |
|||||||||
126,759 |
Match Group, Inc. (a) |
5,475,989 |
|||||||||
47,977 |
Meta Platforms, Inc. (a) |
4,469,537 |
|||||||||
50,956 |
Moderna, Inc. (a) |
7,660,215 |
|||||||||
118,940 |
Okta, Inc. (a) |
6,674,913 |
|||||||||
40,316 |
Palto Alto Networks, Inc. (a) |
6,917,822 |
|||||||||
58,425 |
Paychex, Inc. |
6,912,262 |
|||||||||
40,099 |
VeriSign, Inc. (a) |
8,038,246 |
|||||||||
38,056 |
Verisk Analytics, Inc. Class A |
6,957,778 |
|||||||||
46,088 |
Workday, Inc. (a) |
7,181,432 |
|||||||||
41,410 |
Zscaler, Inc. (a) |
6,381,281 |
|||||||||
78,038,577 |
|||||||||||
Publishing Industries - 10.5% |
|||||||||||
23,434 |
Adobe Systems, Inc. (a) |
7,463,729 |
|||||||||
29,154 |
ANSYS, Inc. (a) |
6,447,699 |
|||||||||
35,999 |
Autodesk, Inc. (a) |
7,714,586 |
|||||||||
42,726 |
Cadence Design Systems, Inc. (a) |
6,468,289 |
|||||||||
41,043 |
CrowdStrike Holdings, Inc. (a) |
6,616,132 |
|||||||||
76,917 |
Datadog, Inc. (a) |
6,192,588 |
|||||||||
124,048 |
DocuSign, Inc. (a) |
5,991,518 |
|||||||||
16,593 |
Intuit, Inc. |
7,093,507 |
|||||||||
28,678 |
Microsoft Corp. |
6,657,024 |
|||||||||
77,306 |
Splunk, Inc. (a) |
6,424,902 |
|||||||||
22,337 |
Synopsys, Inc. (a) |
6,534,689 |
|||||||||
73,604,663 |
|||||||||||
Rail Transportation - 1.0% |
|||||||||||
238,000 |
CSX Corp. |
6,916,280 |
|||||||||
Rental and Leasing Services - 0.9% |
|||||||||||
59,104 |
Airbnb, Inc. (a) |
6,318,809 |
|||||||||
Securities, Commodity Contracts, and Other Financial Investments and Related Activities - 0.9% |
|||||||||||
433,785 |
Lucid Group, Inc. (a)(b) |
6,198,788 |
|||||||||
Specialty Trade Contractors - 0.7% |
|||||||||||
84,858 |
NetEase.com, Inc. ADR (China) (a) |
4,719,802 |
|||||||||
Telecommunications - 3.0% |
|||||||||||
74,666 |
PayPal Holdings, Inc. (a) |
6,240,584 |
|||||||||
50,151 |
T-Mobile US, Inc. (a) |
7,600,886 |
|||||||||
89,205 |
Zoom Video
Communications, Inc. (a) |
7,443,265 |
|||||||||
21,284,735 |
|||||||||||
Transportation Equipment Manufacturing - 3.1% |
|||||||||||
39,575 |
Honeywell International, Inc. |
8,074,091 |
|||||||||
82,436 |
Paccar, Inc. |
7,982,278 |
|||||||||
23,137 |
Tesla Motors, Inc. (a) |
5,264,593 |
|||||||||
21,320,962 |
|||||||||||
Truck Transportation - 1.1% |
|||||||||||
27,629 |
Old Dominion Freight Line, Inc. |
7,586,923 |
Shares |
Fair Value |
||||||||||
Utilities - 3.8% |
|||||||||||
69,935 |
American Electric Power Co., Inc. |
$ |
6,148,685 |
||||||||
82,022 |
Constellation Energy Corp. |
7,754,360 |
|||||||||
162,439 |
Exelon Corp. |
6,268,521 |
|||||||||
94,974 |
Xcel Energy, Inc. |
6,183,757 |
|||||||||
26,355,323 |
|||||||||||
TOTAL COMMON STOCKS
(Cost $806,517,465) |
$ |
698,843,182 |
|||||||||
SHORT TERM INVESTMENTS - 1.9% |
|||||||||||
Money Market Funds - 1.9% |
|||||||||||
13,201,004 |
Dreyfus Government
Cash Management Institutional Shares, 2.91% (c)(d) |
$ |
13,201,004 |
||||||||
TOTAL SHORT TERM
INVESTMENTS (Cost $13,201,004) |
$ |
13,201,004 |
|||||||||
TOTAL INVESTMENTS
(Cost $819,718,469) - 101.8% |
$ |
712,044,186 |
|||||||||
Liabilities in
Excess of Other Assets - (1.8)% |
(12,368,168 |
) |
|||||||||
TOTAL NET ASSETS - 100.0% |
$ |
699,676,018 |
Percentages are stated as a percent of net assets.
The geographic location of all investments is United States unless otherwise indicated.
(a) Non-income producing security.
(b) A portion of this security represents a security on loan.
(c) Represents annualized seven-day yield at October 31, 2022.
(d) All or a portion of this security represents an investment of securities lending collateral.
ADR - American Depository Receipt
The accompanying notes are an integral part of these financial statements.
DIREXION
ANNUAL REPORT
28
Direxion Work From Home ETF
Schedule of Investments
October 31, 2022
Shares |
Fair Value |
||||||||||
COMMON STOCKS - 99.7% |
|||||||||||
Administrative and Support Services - 6.7% |
|||||||||||
11,654 |
Alibaba Group Holding Ltd. ADR (a) |
$ |
740,961 |
||||||||
4,485 |
Atlassian Corp. (a) |
909,244 |
|||||||||
41,085 |
SentinelOne, Inc. (a) |
938,382 |
|||||||||
2,588,587 |
|||||||||||
Computer and Electronic Product Manufacturing - 21.0% |
|||||||||||
9,647 |
Alphabet, Inc. Class A (a) |
911,738 |
|||||||||
520,142 |
Avaya Holdings Corp. (a)(b) |
821,824 |
|||||||||
2,090 |
Broadcom, Inc. |
982,551 |
|||||||||
23,454 |
Cisco Systems, Inc. |
1,065,515 |
|||||||||
20,929 |
Fortinet, Inc. (a) |
1,196,302 |
|||||||||
8,268 |
International
Business Machines Corp. |
1,143,382 |
|||||||||
22,581 |
Marvell Technology, Inc. |
896,014 |
|||||||||
14,935 |
NetApp, Inc. |
1,034,547 |
|||||||||
8,051,873 |
|||||||||||
Data Processing, Hosting and Related Services - 5.0% |
|||||||||||
24,647 |
RingCentral, Inc. (a) |
875,461 |
|||||||||
9,132 |
VMware, Inc. |
1,027,624 |
|||||||||
1,903,085 |
|||||||||||
Electronics and Appliance Stores - 2.9% |
|||||||||||
31,519 |
Smartsheet, Inc. (a) |
1,100,644 |
|||||||||
Management of Companies and Enterprises - 3.0% |
|||||||||||
60,718 |
America Movil SAB de
CV Series L ADR (Mexico) |
1,142,106 |
|||||||||
Nonstore Retailers - 2.2% |
|||||||||||
8,155 |
Amazon.com, Inc. (a) |
835,398 |
|||||||||
Professional, Scientific, and Technical Services - 23.3% |
|||||||||||
6,583 |
Meta Platforms, Inc. (a) |
613,272 |
|||||||||
46,991 |
Nutanix, Inc. (a) |
1,287,553 |
|||||||||
17,256 |
Okta, Inc. (a) |
968,407 |
|||||||||
5,866 |
Palto Alto Networks, Inc. (a) |
1,006,547 |
|||||||||
221,825 |
Rackspace Technology, Inc. (a)(b) |
1,142,399 |
|||||||||
2,377 |
ServiceNow, Inc. (a) |
1,000,099 |
|||||||||
91,896 |
Sprinklr, Inc. (a) |
850,038 |
|||||||||
6,370 |
Workday, Inc. (a) |
992,573 |
|||||||||
7,148 |
Zscaler, Inc. (a) |
1,101,507 |
|||||||||
8,962,395 |
|||||||||||
Publishing Industries (except Internet) - 30.4% |
|||||||||||
2,781 |
Adobe Systems, Inc. (a) |
885,748 |
|||||||||
263,972 |
Agora, Inc. ADR (a) |
736,482 |
|||||||||
40,316 |
Box, Inc. (a) |
1,171,180 |
|||||||||
6,140 |
CrowdStrike Holdings, Inc. (a) |
989,768 |
|||||||||
7,410 |
CyberArk Software
Ltd. ADR (Israel) (a) |
1,162,703 |
|||||||||
19,149 |
DocuSign, Inc. (a) |
924,897 |
|||||||||
1,291,133 |
Exela Technologies, Inc. (a) |
306,644 |
|||||||||
4,091 |
Microsoft Corp. |
949,644 |
|||||||||
14,175 |
Oracle Corp. |
1,106,642 |
|||||||||
22,596 |
Progress Software Corp. |
1,153,074 |
|||||||||
6,889 |
Salesforce.com, Inc. (a) |
1,120,082 |
|||||||||
15,551 |
Twilio, Inc. (a) |
1,156,528 |
|||||||||
11,663,392 |
Shares |
Fair Value |
||||||||||
Telecommunications - 5.2% |
|||||||||||
219,977 |
8x8, Inc. (a) |
$ |
930,503 |
||||||||
13,032 |
Zoom Video
Communications, Inc. (a) |
1,087,390 |
|||||||||
2,017,893 |
|||||||||||
TOTAL COMMON STOCKS
(Cost $58,862,058) |
$ |
38,265,373 |
|||||||||
SHORT TERM INVESTMENTS - 1.7% |
|||||||||||
Money Market Funds - 1.7% |
|||||||||||
654,039 |
Dreyfus Government
Cash Management Institutional Shares, 2.91% (c)(d) |
$ |
654,039 |
||||||||
TOTAL SHORT TERM
INVESTMENTS (Cost $654,039) |
$ |
654,039 |
|||||||||
TOTAL INVESTMENTS
(Cost $59,516,097) - 101.4%< |